Free Trial

BioXcel Therapeutics (BTAI) Earnings Date, Estimates & Call Transcripts

BioXcel Therapeutics logo
$0.51 -0.06 (-10.54%)
(As of 11/22/2024 ET)
Get BioXcel Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioXcel Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BTAI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BTAI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioXcel Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.69-$0.69-$0.69
Q2 20241-$0.63-$0.63-$0.63
Q3 20241-$0.55-$0.55-$0.55
Q4 20241-$0.49-$0.49-$0.49
FY 20244-$2.36-$2.36-$2.36
Q1 20251-$0.45-$0.45-$0.45
Q2 20251-$0.45-$0.45-$0.45
Q3 20251-$0.39-$0.39-$0.39
Q4 20251-$0.28-$0.28-$0.28
FY 20254($1.57)($1.57)($1.57)

BioXcel Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
8/6/2024Q2 2024-$0.76-$0.21+$0.55-$0.21$0.80M$1.10M    
5/9/2024Q1 2024-$0.68-$0.87 -$0.19-$0.87$0.42M$0.58M    
3/12/2024Q4 2023-$0.98-$0.76+$0.22-$0.76$1.17M$0.38M
11/14/2023Q3 2023-$1.29-$1.72 -$0.43-$1.72$0.84M$0.34M
8/14/2023Q2 2023-$1.72-$1.83 -$0.11-$1.83$0.42M$0.46M    
5/8/2023Q1 2023-$1.56-$1.84 -$0.28-$1.84$0.50M$0.21M    
3/9/2023Q4 2022-$1.49-$1.95 -$0.46-$1.95$1.08M$0.24M    

BioXcel Therapeutics Earnings - Frequently Asked Questions

BioXcel Therapeutics (NASDAQ:BTAI) has a recorded annual revenue of $2.28 million.

BioXcel Therapeutics (NASDAQ:BTAI) has a recorded net income of -$179.05 million. BTAI has generated -$2.16 earnings per share over the last four quarters.

BioXcel Therapeutics's earnings are expected to grow from ($1.80) per share to ($1.51) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:BTAI) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners